{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:44:15Z","timestamp":1791020655111,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T00:00:00Z","timestamp":1306108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Activated platelets have been implicated in playing a major role in transfusion-related acute lung injury (TRALI), as platelets can trigger neutrophils, resulting in vascular damage. We hypothesized that binding of platelet CD40 ligand (CD40L) to endothelial CD40 is essential in the onset of TRALI. Mice were challenged with monoclonal major histocompatibility complex (MHC)-1 antibody which induced TRALI, evidenced by pulmonary oedema, accompanied by significantly elevated bronchoalveolar fluid (BALF) levels of total protein and elevated plasma levels of keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) compared to infusion of isotype antibody (all Ps\u2003&amp;lt;\u20030\u00b705). Treatment with ciglitazone, which inhibits platelet CD40L expression, had no effect on pulmonary and systemic inflammation compared to controls. In addition, treatment with anti-CD40L antibody, which antagonizes all CD40\u2013CD40L interactions, also did not abrogate the TRALI reaction. Furthermore, levels of soluble CD40L were measured in a cohort of cardiac surgery patients, who were followed prospectively for the onset of TRALI after transfusion. Plasma levels of sCD40L at baseline and at time of developing TRALI did not differ between TRALI patients and controls (transfused cardiac surgery patients not developing acute lung injury) (275\u2003\u00b1\u2003192 versus 258\u2003\u00b1\u2003346 and 93\u2003\u00b1\u200382 versus 93\u2003\u00b1\u2003123\u2003pg\/ml, respectively, not significant). In conclusion, these results do not support the idea that the CD40\u2013CD40L interaction is involved in mediating TRALI.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04422.x","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T01:32:41Z","timestamp":1306200761000},"page":"278-284","source":"Crossref","is-referenced-by-count":40,"title":["Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury"],"prefix":"10.1093","volume":"165","author":[{"given":"P R","family":"Tuinman","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Gerards","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Jongsma","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Vlaar","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Boon","sequence":"additional","affiliation":[{"name":"Bioceros, Yalelaan 46, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N P","family":"Juffermans","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,23]]},"reference":[{"key":"2021122708473547900_b1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tmrv.2004.10.001","article-title":"Proceedings of a consensus conference: towards an understanding of TRALI","volume":"19","author":"Goldman","year":"2005","journal-title":"Transfus Med Rev"},{"key":"2021122708473547900_b2","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1097\/01.CCM.0000214292.62276.8E","article-title":"The two-event model of transfusion-related acute lung injury","volume":"34","author":"Silliman","year":"2006","journal-title":"Crit Care Med"},{"key":"2021122708473547900_b3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2002-03-0958","article-title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors","volume":"101","author":"Silliman","year":"2003","journal-title":"Blood"},{"key":"2021122708473547900_b4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1423-0410.2010.01392.x","article-title":"Antibody-mediated (immune) transfusion-related acute lung injury","volume":"100","author":"Bux","year":"2011","journal-title":"Vox Sang"},{"key":"2021122708473547900_b5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1537-2995.1997.37797369448.x","article-title":"The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study","volume":"37","author":"Silliman","year":"1997","journal-title":"Transfusion"},{"key":"2021122708473547900_b6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1537-2995.2003.00385.x","article-title":"Plasma and lipids from stored platelets cause acute lung injury in an animal model","volume":"43","author":"Silliman","year":"2003","journal-title":"Transfusion"},{"key":"2021122708473547900_b7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat Med"},{"key":"2021122708473547900_b8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1172\/JCI27238","article-title":"Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury","volume":"116","author":"Looney","year":"2006","journal-title":"J Clin Invest"},{"key":"2021122708473547900_b9","first-page":"3450","article-title":"Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury","volume":"119","author":"Looney","year":"2009","journal-title":"J Clin Invest"},{"key":"2021122708473547900_b10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation","volume":"92","author":"Inwald","year":"2003","journal-title":"Circ Res"},{"key":"2021122708473547900_b11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40\u2013CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"2021122708473547900_b12","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1073\/pnas.97.13.6930","article-title":"Atherosclerosis: the emerging role of inflammation and the CD40\u2013CD40 ligand system","volume":"97","author":"Phipps","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708473547900_b13","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2006-04-017251","article-title":"Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury","volume":"108","author":"Khan","year":"2006","journal-title":"Blood"},{"key":"2021122708473547900_b14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/1078-0432.CCR-0348-03","article-title":"Soluble CD40 ligand plasma levels in lung cancer","volume":"10","author":"Roselli","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2021122708473547900_b15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"2021122708473547900_b16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.STR.0000154878.58398.14","article-title":"Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis","volume":"36","author":"Novo","year":"2005","journal-title":"Stroke"},{"key":"2021122708473547900_b17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"2021122708473547900_b18","doi-asserted-by":"crossref","first-page":"C1592","DOI":"10.1152\/ajpcell.00540.2001","article-title":"A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release","volume":"283","author":"Wyman","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"2021122708473547900_b19","first-page":"651","article-title":"Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome","volume":"152","author":"Adawi","year":"1998","journal-title":"Am J Pathol"},{"key":"2021122708473547900_b20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1165\/rcmb.2003-0197OC","article-title":"CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury","volume":"30","author":"Hashimoto","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021122708473547900_b21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/clin.1998.4606","article-title":"Blockade of CD40\u2013CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis","volume":"89","author":"Adawi","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708473547900_b22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1538-7836.2007.02412.x","article-title":"Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion","volume":"5","author":"Kaufman","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2021122708473547900_b23","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.0000019068.32280.B3","article-title":"Cardiopulmonary bypass induces release of soluble CD40 ligand","volume":"105","author":"Nannizzi-Alaimo","year":"2002","journal-title":"Circulation"},{"key":"2021122708473547900_b24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0b013e31819599b6","article-title":"The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice","volume":"37","author":"Stegenga","year":"2009","journal-title":"Crit Care Med"},{"key":"2021122708473547900_b25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2004-03-0926","article-title":"Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes","volume":"104","author":"Akbiyik","year":"2004","journal-title":"Blood"},{"key":"2021122708473547900_b26","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.0000069272.06194.91","article-title":"Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease","volume":"107","author":"Marx","year":"2003","journal-title":"Circulation"},{"key":"2021122708473547900_b27","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.178.5.1567","article-title":"In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39","volume":"178","author":"Foy","year":"1993","journal-title":"J Exp Med"},{"key":"2021122708473547900_b28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2008.02.013","article-title":"Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo","volume":"335","author":"Stax","year":"2008","journal-title":"J Immunol Methods"},{"key":"2021122708473547900_b29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00134-010-1802-z","article-title":"Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies","volume":"36","author":"Vlaar","year":"2010","journal-title":"Intens Care Med"},{"key":"2021122708473547900_b30","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1182\/blood-2010-10-313973","article-title":"The incidence, risk factors and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case control study","volume":"117","author":"Vlaar","year":"2011","journal-title":"Blood"},{"key":"2021122708473547900_b31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review","volume":"33","author":"Toy","year":"2005","journal-title":"Crit Care Med"},{"key":"2021122708473547900_b32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/CCM.0b013e3181cc4d4b","article-title":"Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case\u2013control study","volume":"38","author":"Vlaar","year":"2010","journal-title":"Crit Care Med"},{"key":"2021122708473547900_b33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"2021122708473547900_b34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11739-007-0076-0","article-title":"CD40\/CD40L system and vascular disease","volume":"2","author":"Santilli","year":"2007","journal-title":"Intern Emerg Med"},{"key":"2021122708473547900_b35","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.4049\/jimmunol.168.8.3747","article-title":"Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin","volume":"168","author":"Nierkens","year":"2002","journal-title":"J Immunol"},{"key":"2021122708473547900_b36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood-2009-10-248732","article-title":"Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model","volume":"116","author":"Vlaar","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2021122708473547900_b37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199600001-00004","article-title":"Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors","volume":"27","author":"Cameron","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021122708473547900_b38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0003-4975(93)90342-F","article-title":"Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators","volume":"56","author":"Gillinov","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"2021122708473547900_b39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1537-2995.2006.00979.x","article-title":"An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions","volume":"46","author":"Blumberg","year":"2006","journal-title":"Transfusion"},{"key":"2021122708473547900_b40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s000110300009","article-title":"CD40 ligation triggers COX-2 expression in endothelial cells: evidence that CD40-mediated IL-6 synthesis is COX-2-dependent","volume":"52","author":"Dongari-Bagtzoglou","year":"2003","journal-title":"Inflamm Res"},{"key":"2021122708473547900_b41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s004280000239","article-title":"Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII)","volume":"437","author":"Hakkinen","year":"2000","journal-title":"Virchows Arch"},{"key":"2021122708473547900_b42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1537-2995.2001.41080997.x","article-title":"Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions","volume":"41","author":"Uhlmann","year":"2001","journal-title":"Transfusion"},{"key":"2021122708473547900_b43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.289.15.1941","article-title":"Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions","volume":"289","author":"Hebert","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"2021122708473547900_b44","first-page":"P4","article-title":"Transfusion-related acute lung injury in cardiac surgery patients is hemerus characterized by systemic inflammation prior to onset of disease, followed by pulmonary activation of inflammation and coagulopathy","volume":"50","author":"Vlaar","year":"2010","journal-title":"Transfusion"},{"key":"2021122708473547900_b45","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","article-title":"Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients","volume":"52","author":"Danese","year":"2003","journal-title":"Gut"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04422.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/165\/2\/278\/41908763\/j.1365-2249.2011.04422.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/165\/2\/278\/41908763\/j.1365-2249.2011.04422.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:23Z","timestamp":1641054203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/165\/2\/278\/6422872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,23]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,5,23]]},"published-print":{"date-parts":[[2011,7,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04422.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,8]]},"published":{"date-parts":[[2011,5,23]]}}}